RECRUITING

Thalamus Seizure Detection With a Deep Brain Stimulator System

Description

The purpose of this study is to determine the feasibility of chronic ambulatory thalamus seizure detection. The sensitivity, specificity, and false alarm rate of thalamus seizure detection will be calculated using recordings from a deep brain stimulation system, assessed relative to concurrent gold-standard video-EEG monitoring collected in the in-patient setting (epilepsy monitoring unit), in 5 patients with drug resistant epilepsy.

Conditions

Epilepsy; Seizure
Talk to us

Related Conditions:

Epilepsy; Seizure

Study Overview

On this page

Study Details

Study overview

The purpose of this study is to determine the feasibility of chronic ambulatory thalamus seizure detection. The sensitivity, specificity, and false alarm rate of thalamus seizure detection will be calculated using recordings from a deep brain stimulation system, assessed relative to concurrent gold-standard video-EEG monitoring collected in the in-patient setting (epilepsy monitoring unit), in 5 patients with drug resistant epilepsy.

Seizure Detection With a Deep Brain Stimulation System

Thalamus Seizure Detection With a Deep Brain Stimulator System

Condition
Epilepsy; Seizure
Intervention / Treatment

-

Contacts and Locations

Rochester

Mayo Clinic in Rochester, Rochester, Minnesota, United States, 55905

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * 18 years of age and older.
  • * Implanted with a clinical DBS system for epilepsy with brain recording capabilities (Medtronic Percept™ DBS).
  • * Subject or legally authorized representative is able to understand study procedures and to comply with them for the entire length of the study.
  • * Health status or any clinical conditions (e.g., life expectancy, co-existing disease) that, in the opinion of the site investigator, would pose undue risk to undergo epilepsy monitoring unit evaluation for the purpose of seizure characterization.
  • * Women will verify not pregnant, and if applicable, have urine pregnancy test.
  • * Current drug or alcohol use or dependence that, in the opinion of the site investigator, would interfere with adherence to study requirements.
  • * Inability or unwillingness of individual or legal guardian/representative to give written informed consent.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Mayo Clinic,

Nicholas Gregg, PRINCIPAL_INVESTIGATOR, Mayo Clinic

Study Record Dates

2027-05